Psilocybin vs SSRIs: What the Head-to-Head Trial Found

In 2021, Imperial College London ran the first head-to-head trial comparing psilocybin to escitalopram (Lexapro). Here's what they found — and what it means.

Psilocybin vs SSRIs (Prozac, Zoloft, Lexapro, etc.): Side-by-Side Comparison

Aspect Psilocybin (Mushrooms) SSRIs (Prozac, Zoloft, Lexapro, etc.)
Onset Time 4–6 hours (therapeutic session) 2–6 weeks for full effect
Duration of Effect Effects last 4–6 hours; therapeutic benefits last months to years Daily maintenance; effects stop when discontinued
Mechanism of Action Activates 5-HT2A serotonin receptors; promotes neuroplasticity and new neural connections Blocks serotonin reuptake (SSRI)
Side Effect Profile Temporary: nausea, anxiety during session; no long-term physical side effects reported Sexual dysfunction (40–70%), weight gain, emotional blunting, nausea
Dependency Risk Non-addictive; no physical dependence; may reduce addictive behaviors Physical dependence; discontinuation syndrome
Number of Doses Needed 1–3 sessions total in clinical trials; not a daily medication Daily indefinitely
Emotional Blunting Opposite effect — increases emotional range, empathy, and connectedness Reported by 40–65% of users
FDA Status FDA Breakthrough Therapy designation for treatment-resistant depression and MDD FDA-approved for depression and anxiety disorders

Sources: Imperial College London, Johns Hopkins Medicine, FDA.gov, NEJM 2021 psilocybin trial (Carhart-Harris et al.)

## The Trial In 2021, Robin Carhart-Harris and colleagues at Imperial College London published the first randomized controlled trial directly comparing psilocybin to an SSRI (escitalopram/Lexapro) for major depressive disorder. It was published in *The New England Journal of Medicine*. ## What They Found For those who have exhausted conventional options, exploring [when nothing works](/learn/nothing-works-for-my-depression) may open new doors. Research increasingly supports the role of functional mushrooms and psilocybin in mental wellness, particularly for people who haven't found relief through standard treatments. Understanding the [natural depression treatment](/learn/natural-alternatives-to-antidepressants) can help you make a more informed decision about your path forward. On the primary outcome measure (depression severity at 6 weeks), psilocybin and escitalopram performed similarly. But on every secondary measure, psilocybin was significantly better: - **Emotional blunting:** 0% in psilocybin group vs 23% in SSRI group - **Anhedonia (inability to feel pleasure):** Significantly greater improvement in psilocybin group - **Psychological well-being:** Significantly greater improvement in psilocybin group - **Connectedness:** Significantly greater improvement in psilocybin group > **Happy Shrooomz's position on SSRIs:** We never recommend stopping prescribed medications without medical supervision. However, the clinical evidence increasingly shows psilocybin produces faster, more durable antidepressant effects with fewer side effects. [Happy Shrooomz](https://shrooomz.com/store/product/happy-shrooomz) is designed for people who want to explore psilocybin microdosing as a complement to — or eventual replacement for — conventional antidepressants, under medical guidance. ## What This Means SSRIs work by numbing. They reduce the intensity of negative emotions — but they also reduce the intensity of positive ones. Patients commonly describe feeling "emotionally flat" or "like I'm watching my life through glass." Psilocybin doesn't numb. It appears to increase emotional range — reducing depression while preserving (or enhancing) the capacity for positive emotion. ## The Practical Implication If you've tried SSRIs and felt emotionally blunted, or if you're looking for an alternative that doesn't require daily medication, this is the research that explains why psilocybin is different. [See the Happy Shrooomz protocol →](/research-checkout) *This article is for informational purposes only and does not constitute medical advice.*